Prof. Dominic Walsh has worked on the molecular pathology of neurodegeneration since December 1991, has authored over 150 research articles, written several widely cited reviews, and given over 100 invited lectures and webinars.  He has served as an Editor or Editorial Advisor for several journals and as an ad hoc reviewer for the world’s leading biomedical journals.  Dominic has also been a consultant and/or SAB member for several academic institutions, public bodies, and for many pharmaceutical and biotechnology companies.  As an academic scientist his research was supported by multiple agencies, grants from industry, and donations from the public.  He was named one of The World’s Most Influential Scientific Minds by Thomson Reuters and ranked among the top 1% of researchers in the field of Neuroscience and Behavior 2014 – 2016.

Dominic joined Biogen in September 2018 as Head of the Alzheimer’s Disease & Dementia Research Unit leading early research through Phase 2 clinical trials.  In March 2020 Dominic became head of the newly founded Neurodegenerative Diseases Research Unit (NDRU) where, until his retirement from Biogen in April 2024, he led research through IND on Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease.  On two separate occasions (2020-2021 and 2023-2024) he served as the Interim Head of the Neuromuscular & Muscle Diseases Research Unit and was responsible for research efforts on ALS and muscle disease.

Currently, Dominic is an SAB member for several Pharmaceutical and Biotech companies.  He is an Honorary Professor at the Institute of Neurology, University College London and an Adjunct Professor at the School of Medicine, Trinity College Dublin.  Dominic also retains a position at Brigham & Women’s Hospital and Harvard Medical School.